Covered recipient · General Payments record
CARLOS ISAAC PACHECO CANO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$657.21
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.10 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $78.56 | 4 |
| ABBVIE INC. | $72.32 | 4 |
| PFIZER INC. | $59.09 | 3 |
| Phathom Pharmaceuticals, Inc. | $46.04 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.06 | 2 |
| Exact Sciences Corporation | $23.16 | 1 |
| GlaxoSmithKline, LLC. | $15.99 | 1 |
| Amgen Inc. | $13.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.17 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105167408 | CMS |
| ABBVIE INC. | $23.16 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105167410 | CMS |
| ABBVIE INC. | $16.17 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105167412 | CMS |
| ABBVIE INC. | $15.82 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105167414 | CMS |
| Amgen Inc. | $13.88 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117345198 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.75 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118114081 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.31 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118114083 | CMS |
| Exact Sciences Corporation | $23.16 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114467011 | CMS |
| GlaxoSmithKline, LLC. | $15.99 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116397122 | CMS |
| Lilly USA, LLC | $22.75 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136035816 | CMS |
| Lilly USA, LLC | $21.30 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136086700 | CMS |
| Lilly USA, LLC | $16.94 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083274 | CMS |
| Lilly USA, LLC | $17.57 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136089640 | CMS |
| PFIZER INC. | $17.03 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131523750 | CMS |
| PFIZER INC. | $18.34 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131576681 | CMS |
| PFIZER INC. | $23.72 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131523961 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.52 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151105185 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.52 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151105187 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.